CD19-directed chimeric antigen receptor t cell therapy

Papers on CD19-directed chimeric antigen receptor t cell therapy

1 paper1 new in 30 days

Monday, November 2

Nature Genetics

Blood-cell clones linked to complications after lymphoma therapy

An observational study in patients with lymphoma linked expanding blood-cell clones to poorer immune recovery and treatment-related blood cancers after engineered…An observational study in patients with lymphoma linked expanding blood-cell clones to poorer immune recovery and treatment-related blood cancers after engineered immune-cell therapy.

Figure from Nature Genetics
Cohort study in peopleLymphoma